Does Clinical Evidence of Heterogeneity Impact Treatment Selection? A Case Study of Abiraterone for Metastatic Prostate Cancer

Boshen Jiao(University of Southern California), Anirban Basu(University of Washington)
Journal of the National Comprehensive Cancer Network
October 1, 2022
10.6004/jnccn.2022.7044
Cited by 2

Related Papers

No related papers found

Powered by citation graph analysis